ICD125K ;ALB/DMR - YEARLY DRG UPDATE; October 01, 2025@15:42
;;18.0;DRG Grouper;**125**;October 20, 2000;Build 4
;Per VA Directive 6402, this routine should not be modified.
; Updates for DRGS 810-999
Q
;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
;;810^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT CC/MCC^1.0466^2.6
;;811^16^MED^RED BLOOD CELL DISORDERS WITH MCC^1.4043^3.7
;;812^16^MED^RED BLOOD CELL DISORDERS WITHOUT MCC^0.9182^2.7
;;813^16^MED^COAGULATION DISORDERS^1.5253^3.6
;;814^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC^2.1267^4.7
;;815^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC^1.014^2.9
;;816^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC^0.632^2
;;817^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH MCC^1.688^3.6
;;818^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH CC^1.0542^2.7
;;819^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITHOUT CC/MCC^0.8599^1.6
;;820^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC^5.8648^10.7
;;821^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC^2.2386^3.3
;;822^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.204^1.5
;;823^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH MCC^4.5848^10.1
;;824^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH CC^2.2656^4.9
;;825^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITHOUT CC/MCC^1.3494^2.2
;;826^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC^4.6778^8.4
;;827^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC^2.3112^4
;;828^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.7038^2.4
;;829^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC^3.16^5.9
;;830^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC^1.505^2.1
;;831^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH MCC^1.2025^3.3
;;832^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH CC^0.7216^2.6
;;833^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITHOUT CC/MCC^0.5229^1.7
;;834^17^MED^ACUTE LEUKEMIA WITH MCC^5.4899^9.6
;;835^17^MED^ACUTE LEUKEMIA WITH CC^2.0858^4.4
;;836^17^MED^ACUTE LEUKEMIA WITHOUT CC/MCC^1.2195^2.9
;;837^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC^4.8043^10.2
;;838^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT^2.0874^5.1
;;839^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^1.4439^4
;;840^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC^3.2349^6.8
;;841^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC^1.6314^4
;;842^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC^1.0104^2.6
;;843^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC^1.9948^5.4
;;844^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC^1.2174^3.7
;;845^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC^0.8516^2.4
;;846^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC^2.5925^5.8
;;847^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC^1.3082^3.8
;;848^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^0.8494^2.6
;;849^17^MED^RADIOTHERAPY^2.7095^7.1
;;850^17^SURG^ACUTE LEUKEMIA WITH OTHER PROCEDURES^8.6595^15.3
;;853^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC^4.9386^9.3
;;854^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH CC^1.9981^4.9
;;855^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITHOUT CC/MCC^1.4972^2.9
;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH MCC^4.5487^9.1
;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH CC^2.1415^5.4
;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITHOUT CC/MCC^1.3929^3.4
;;862^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MCC^1.8237^5
;;863^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITHOUT MCC^0.9979^3.3
;;864^18^MED^FEVER AND INFLAMMATORY CONDITIONS^0.8877^2.6
;;865^18^MED^VIRAL ILLNESS WITH MCC^1.4983^4
;;866^18^MED^VIRAL ILLNESS WITHOUT MCC^0.8696^2.7
;;867^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH MCC^2.0932^5.4
;;868^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH CC^1.0311^3.4
;;869^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITHOUT CC/MCC^0.7297^2.4
;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS^6.9118^12.7
;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC^1.9425^4.8
;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC^1.0233^3.4
;;876^19^SURG^O.R. PROCEDURES WITH PRINCIPAL DIAGNOSIS OF MENTAL ILLNESS^3.8649^7.3
;;880^19^MED^ACUTE ADJUSTMENT REACTION AND PSYCHOSOCIAL DYSFUNCTION^0.9602^2.8
;;881^19^MED^DEPRESSIVE NEUROSES^0.9409^4.1
;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^1.0738^3.4
;;883^19^MED^DISORDERS OF PERSONALITY AND IMPULSE CONTROL^1.9663^5.8
;;884^19^MED^ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY^1.6089^4.6
;;885^19^MED^PSYCHOSES^1.3968^6.5
;;886^19^MED^BEHAVIORAL AND DEVELOPMENTAL DISORDERS^2.0753^5.9
;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^1.0709^3.1
;;894^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.6169^2
;;895^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY^1.4156^7.2
;;896^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC^1.7451^4.8
;;897^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC^0.8828^3.3
;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH MCC^4.1966^8.4
;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH CC^1.9145^4.7
;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITHOUT CC/MCC^1.1696^2.6
;;904^21^SURG^SKIN GRAFTS FOR INJURIES WITH CC/MCC^3.6731^6.6
;;905^21^SURG^SKIN GRAFTS FOR INJURIES WITHOUT CC/MCC^1.4318^3
;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.7624^2.8
;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH MCC^3.8393^6.8
;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH CC^1.9952^3.6
;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITHOUT CC/MCC^1.3127^2.2
;;913^21^MED^TRAUMATIC INJURY WITH MCC^1.6346^3.9
;;914^21^MED^TRAUMATIC INJURY WITHOUT MCC^0.8855^2.5
;;915^21^MED^ALLERGIC REACTIONS WITH MCC^1.6816^3.5
;;916^21^MED^ALLERGIC REACTIONS WITHOUT MCC^0.6663^1.8
;;917^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITH MCC^1.5684^3.7
;;918^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MCC^0.8571^2.4
;;919^21^MED^COMPLICATIONS OF TREATMENT WITH MCC^1.8308^4.3
;;920^21^MED^COMPLICATIONS OF TREATMENT WITH CC^1.0023^2.8
;;921^21^MED^COMPLICATIONS OF TREATMENT WITHOUT CC/MCC^0.6884^2.1
;;922^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITH MCC^1.7494^4.2
;;923^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITHOUT MCC^1.0177^2.8
;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITH SKIN GRAFT^18.4302^24
;;928^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITH CC/MCC^7.1727^12.4
;;929^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITHOUT CC/MCC^3.2208^6.1
;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITHOUT SKIN GRAFT^3.8167^3
;;934^22^MED^FULL THICKNESS BURN WITHOUT SKIN GRAFT OR INHALATION INJURY^2.2106^4.9
;;935^22^MED^NON-EXTENSIVE BURNS^2.06^3.9
;;939^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH MCC^3.6285^6.3
;;940^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH CC^2.3369^3.1
;;941^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITHOUT CC/MCC^2.0277^1.9
;;945^23^MED^REHABILITATION WITH CC/MCC^1.5486^5.6
;;946^23^MED^REHABILITATION WITHOUT CC/MCC^1.1468^4.4
;;947^23^MED^SIGNS AND SYMPTOMS WITH MCC^1.2694^3.7
;;948^23^MED^SIGNS AND SYMPTOMS WITHOUT MCC^0.8005^2.6
;;949^23^MED^AFTERCARE WITH CC/MCC^1.1897^4.3
;;950^23^MED^AFTERCARE WITHOUT CC/MCC^0.6277^3.2
;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.556^1.8
;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^6.7311^8.7
;;956^24^SURG^LIMB REATTACHMENT, HIP AND FEMUR PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA^3.763^5.9
;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH MCC^7.6199^10.1
;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH CC^4.2139^6.5
;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^2.9441^3.8
;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH MCC^2.7338^5.5
;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH CC^1.5326^3.9
;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^0.9405^2.5
;;969^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITH MCC^6.1213^11.7
;;970^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITHOUT MCC^2.6374^7.5
;;974^25^MED^HIV WITH MAJOR RELATED CONDITION WITH MCC^2.886^6.6
;;975^25^MED^HIV WITH MAJOR RELATED CONDITION WITH CC^1.295^3.9
;;976^25^MED^HIV WITH MAJOR RELATED CONDITION WITHOUT CC/MCC^0.8945^3
;;977^25^MED^HIV WITH OR WITHOUT OTHER RELATED CONDITION^1.2676^3.6
;;981^ ^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^4.6918^8.4
;;982^ ^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^2.4585^4
;;983^ ^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.714^2
;;987^ ^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^3.4284^7.8
;;988^ ^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^1.6436^4
;;989^ ^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.1992^2.3
;;998^ ^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.0^0.0
;;999^ ^**^UNGROUPABLE^0.0^0.0
;;EXIT
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HICD125K 10650 printed Jan 29, 2026@14:46:06 Page 2
ICD125K ;ALB/DMR - YEARLY DRG UPDATE; October 01, 2025@15:42
+1 ;;18.0;DRG Grouper;**125**;October 20, 2000;Build 4
+2 ;Per VA Directive 6402, this routine should not be modified.
+3 ; Updates for DRGS 810-999
+4 QUIT
+5 ;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
+1 ;;810^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT CC/MCC^1.0466^2.6
+2 ;;811^16^MED^RED BLOOD CELL DISORDERS WITH MCC^1.4043^3.7
+3 ;;812^16^MED^RED BLOOD CELL DISORDERS WITHOUT MCC^0.9182^2.7
+4 ;;813^16^MED^COAGULATION DISORDERS^1.5253^3.6
+5 ;;814^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC^2.1267^4.7
+6 ;;815^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC^1.014^2.9
+7 ;;816^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC^0.632^2
+8 ;;817^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH MCC^1.688^3.6
+9 ;;818^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH CC^1.0542^2.7
+10 ;;819^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITHOUT CC/MCC^0.8599^1.6
+11 ;;820^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC^5.8648^10.7
+12 ;;821^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC^2.2386^3.3
+13 ;;822^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.204^1.5
+14 ;;823^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH MCC^4.5848^10.1
+15 ;;824^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH CC^2.2656^4.9
+16 ;;825^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITHOUT CC/MCC^1.3494^2.2
+17 ;;826^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC^4.6778^8.4
+18 ;;827^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC^2.3112^4
+19 ;;828^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.7038^2.4
+20 ;;829^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC^3.16^5.9
+21 ;;830^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC^1.505^2.1
+22 ;;831^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH MCC^1.2025^3.3
+23 ;;832^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH CC^0.7216^2.6
+24 ;;833^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITHOUT CC/MCC^0.5229^1.7
+25 ;;834^17^MED^ACUTE LEUKEMIA WITH MCC^5.4899^9.6
+26 ;;835^17^MED^ACUTE LEUKEMIA WITH CC^2.0858^4.4
+27 ;;836^17^MED^ACUTE LEUKEMIA WITHOUT CC/MCC^1.2195^2.9
+28 ;;837^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC^4.8043^10.2
+29 ;;838^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT^2.0874^5.1
+30 ;;839^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^1.4439^4
+31 ;;840^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC^3.2349^6.8
+32 ;;841^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC^1.6314^4
+33 ;;842^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC^1.0104^2.6
+34 ;;843^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC^1.9948^5.4
+35 ;;844^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC^1.2174^3.7
+36 ;;845^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC^0.8516^2.4
+37 ;;846^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC^2.5925^5.8
+38 ;;847^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC^1.3082^3.8
+39 ;;848^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^0.8494^2.6
+40 ;;849^17^MED^RADIOTHERAPY^2.7095^7.1
+41 ;;850^17^SURG^ACUTE LEUKEMIA WITH OTHER PROCEDURES^8.6595^15.3
+42 ;;853^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC^4.9386^9.3
+43 ;;854^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH CC^1.9981^4.9
+44 ;;855^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITHOUT CC/MCC^1.4972^2.9
+45 ;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH MCC^4.5487^9.1
+46 ;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH CC^2.1415^5.4
+47 ;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITHOUT CC/MCC^1.3929^3.4
+48 ;;862^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MCC^1.8237^5
+49 ;;863^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITHOUT MCC^0.9979^3.3
+50 ;;864^18^MED^FEVER AND INFLAMMATORY CONDITIONS^0.8877^2.6
+51 ;;865^18^MED^VIRAL ILLNESS WITH MCC^1.4983^4
+52 ;;866^18^MED^VIRAL ILLNESS WITHOUT MCC^0.8696^2.7
+53 ;;867^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH MCC^2.0932^5.4
+54 ;;868^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH CC^1.0311^3.4
+55 ;;869^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITHOUT CC/MCC^0.7297^2.4
+56 ;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS^6.9118^12.7
+57 ;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC^1.9425^4.8
+58 ;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC^1.0233^3.4
+59 ;;876^19^SURG^O.R. PROCEDURES WITH PRINCIPAL DIAGNOSIS OF MENTAL ILLNESS^3.8649^7.3
+60 ;;880^19^MED^ACUTE ADJUSTMENT REACTION AND PSYCHOSOCIAL DYSFUNCTION^0.9602^2.8
+61 ;;881^19^MED^DEPRESSIVE NEUROSES^0.9409^4.1
+62 ;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^1.0738^3.4
+63 ;;883^19^MED^DISORDERS OF PERSONALITY AND IMPULSE CONTROL^1.9663^5.8
+64 ;;884^19^MED^ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY^1.6089^4.6
+65 ;;885^19^MED^PSYCHOSES^1.3968^6.5
+66 ;;886^19^MED^BEHAVIORAL AND DEVELOPMENTAL DISORDERS^2.0753^5.9
+67 ;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^1.0709^3.1
+68 ;;894^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.6169^2
+69 ;;895^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY^1.4156^7.2
+70 ;;896^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC^1.7451^4.8
+71 ;;897^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC^0.8828^3.3
+72 ;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH MCC^4.1966^8.4
+73 ;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH CC^1.9145^4.7
+74 ;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITHOUT CC/MCC^1.1696^2.6
+75 ;;904^21^SURG^SKIN GRAFTS FOR INJURIES WITH CC/MCC^3.6731^6.6
+76 ;;905^21^SURG^SKIN GRAFTS FOR INJURIES WITHOUT CC/MCC^1.4318^3
+77 ;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.7624^2.8
+78 ;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH MCC^3.8393^6.8
+79 ;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH CC^1.9952^3.6
+80 ;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITHOUT CC/MCC^1.3127^2.2
+81 ;;913^21^MED^TRAUMATIC INJURY WITH MCC^1.6346^3.9
+82 ;;914^21^MED^TRAUMATIC INJURY WITHOUT MCC^0.8855^2.5
+83 ;;915^21^MED^ALLERGIC REACTIONS WITH MCC^1.6816^3.5
+84 ;;916^21^MED^ALLERGIC REACTIONS WITHOUT MCC^0.6663^1.8
+85 ;;917^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITH MCC^1.5684^3.7
+86 ;;918^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MCC^0.8571^2.4
+87 ;;919^21^MED^COMPLICATIONS OF TREATMENT WITH MCC^1.8308^4.3
+88 ;;920^21^MED^COMPLICATIONS OF TREATMENT WITH CC^1.0023^2.8
+89 ;;921^21^MED^COMPLICATIONS OF TREATMENT WITHOUT CC/MCC^0.6884^2.1
+90 ;;922^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITH MCC^1.7494^4.2
+91 ;;923^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITHOUT MCC^1.0177^2.8
+92 ;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITH SKIN GRAFT^18.4302^24
+93 ;;928^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITH CC/MCC^7.1727^12.4
+94 ;;929^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITHOUT CC/MCC^3.2208^6.1
+95 ;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITHOUT SKIN GRAFT^3.8167^3
+96 ;;934^22^MED^FULL THICKNESS BURN WITHOUT SKIN GRAFT OR INHALATION INJURY^2.2106^4.9
+97 ;;935^22^MED^NON-EXTENSIVE BURNS^2.06^3.9
+98 ;;939^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH MCC^3.6285^6.3
+99 ;;940^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH CC^2.3369^3.1
+100 ;;941^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITHOUT CC/MCC^2.0277^1.9
+101 ;;945^23^MED^REHABILITATION WITH CC/MCC^1.5486^5.6
+102 ;;946^23^MED^REHABILITATION WITHOUT CC/MCC^1.1468^4.4
+103 ;;947^23^MED^SIGNS AND SYMPTOMS WITH MCC^1.2694^3.7
+104 ;;948^23^MED^SIGNS AND SYMPTOMS WITHOUT MCC^0.8005^2.6
+105 ;;949^23^MED^AFTERCARE WITH CC/MCC^1.1897^4.3
+106 ;;950^23^MED^AFTERCARE WITHOUT CC/MCC^0.6277^3.2
+107 ;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.556^1.8
+108 ;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^6.7311^8.7
+109 ;;956^24^SURG^LIMB REATTACHMENT, HIP AND FEMUR PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA^3.763^5.9
+110 ;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH MCC^7.6199^10.1
+111 ;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH CC^4.2139^6.5
+112 ;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^2.9441^3.8
+113 ;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH MCC^2.7338^5.5
+114 ;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH CC^1.5326^3.9
+115 ;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^0.9405^2.5
+116 ;;969^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITH MCC^6.1213^11.7
+117 ;;970^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITHOUT MCC^2.6374^7.5
+118 ;;974^25^MED^HIV WITH MAJOR RELATED CONDITION WITH MCC^2.886^6.6
+119 ;;975^25^MED^HIV WITH MAJOR RELATED CONDITION WITH CC^1.295^3.9
+120 ;;976^25^MED^HIV WITH MAJOR RELATED CONDITION WITHOUT CC/MCC^0.8945^3
+121 ;;977^25^MED^HIV WITH OR WITHOUT OTHER RELATED CONDITION^1.2676^3.6
+122 ;;981^ ^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^4.6918^8.4
+123 ;;982^ ^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^2.4585^4
+124 ;;983^ ^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.714^2
+125 ;;987^ ^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^3.4284^7.8
+126 ;;988^ ^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^1.6436^4
+127 ;;989^ ^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.1992^2.3
+128 ;;998^ ^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.0^0.0
+129 ;;999^ ^**^UNGROUPABLE^0.0^0.0
+130 ;;EXIT
